Radiation Oncologist, Associate Professor, Cleveland Clinic Taussig Cancer Center. Director of #SBRT.
Joined June 2018
- Tweets 86
- Following 292
- Followers 520
- Likes 127
7 Photos and videos
Kevin Stephans MD retweeted
22 Oct 2022
If you want to learn more about @ClevelandClinic radiation oncology during the #ASTRO22 meeting, please stop by our booth #2596. We look forward to connecting with you. @bikeVeloSano @CleClinicMD #CleClinicCancer
32
75
27 Feb 2022
(4/4) PET scan negative for residual disease too. Will follow. Integration of multidisciplinary care and access to new technology can open doors. Grateful to the brave patients who have walked this path, amazed to see what they can accomplish in treatment and in life.
7
17
27 Feb 2022
(3/4)Now over 2 years from treatment with no radiographic evidence of residual disease. Intact liver function and excellent performance status. Fortunate to work with excellent colleagues in medical oncology, interventional radiology, and hepatobiliary surgery @ClevelandClinic.
9
25
27 Feb 2022
(2/4)Treated w 4 cycles gem-cis, followed by y90 and consolidative high dose hypofractionated XRT (a/w improved survival compared to conventional XRT by @haydencrane5 and Randa Tao). Lower dose PTV’s on edge to maintain normal tissue. 60-67.5 Gy/15 fx to center. higher better.
3
13
29
27 Feb 2022
(1/4)As Cholangiocarcinoma awareness month draws to close wanted to point out aggressive multi-disciplinary treatment offers opportunity for success w unresectable CCA. 18 cm tumor w outflow obstruction resulting in aborted trisegmentectomy due to unstable BP and liver bleeding.
1
11
21
Kevin Stephans MD retweeted
4 Dec 2021
The @ClevelandClinic 14th Annual International Symposium on #SBRT and #SRS will be held February 25-27, 2022, bringing together world leaders in brain, spine and body-targeted stereotactic radiation modalities and techniques. Join us! ccfcme.org/sbrt
2
10
26
Kevin Stephans MD retweeted
6 Mar 2021
New publication with @jihyunRadOnc. 🌟Our observations suggest that early antiarrhythmic effects after cardiac radioablation result from conduction disturbances and membrane potential alterations without necrosis. (ahajournals.org/doi/10.1161/…)
2
16
40
Kevin Stephans MD retweeted
24 Mar 2021
I did a thing today...I volunteered to give vaccines with the Cuyahoga County Health Dept and the Medical Reserve Corps. It felt great to help move us forward in the fight against COVID19.
2
5
29
Kevin Stephans MD retweeted
16 Mar 2021
Excellent review article in Seminar of Radiation Oncology by @danielrgomez44 about consolidative thoracic radiotherapy in oligometastatic lung cancer
#radonc sciencedirect.com/science/ar…
17
59
17 Mar 2021
Prospective contour review takes effort, but @DrAndrewVassil has that covered. Great to work with colleagues who go the extra mile every day. #PatientSafetyAwarenessWeek
17 Mar 2021
Prospective contour review is done across all disease sites through all locations @ClevelandClinic to improve patient safety. #PatientSafetyAwarenessWeek #PSAW21 #ROSafety @MichaelWellerMD @videtig @TimSmile_MD @6mvphotons @WinstonVuong
1
3
Kevin Stephans MD retweeted
2 Mar 2021
Full publication of randomised Scandinavian dose escalation trial for LS SCLC
45Gy / 30 Fx / 3 weeks vs 60Gy / 40 Fx / 4 weeks
⬆️ 2a OS 74.2% vs 48.1%
⬆️ Med OS 37.2 mo vs 22.6 mo
↗️ Med PFS 18.6 mo vs 10.9 mo (p=0.13)
➡️ Grade 3 toxicity and SAEs
#radonc
tinyurl.com/ryrfztj2
3
70
150
Kevin Stephans MD retweeted
22 Feb 2021
Example images of case to illustrate —strong team enrolling over 50% complete despite covid @DrSpratticus @RTendulkarMD @MdStephans and John Christodouleas UPenn and Tyler Robbins U Colorado
1
1
3
Kevin Stephans MD retweeted
Great summary for role of adjuvant versus salvage XRT is important for our patients with biochemical recurrent #prostatecancer - @felixfeng with 22-gene classifier from @NRGonc RTOG 9601 trial that may help us define high risk populations needing ADT. @ASCO #GU21
28
42
Kevin Stephans MD retweeted
12 Feb 2021
I’m thrilled to share our newly published work, “Revisiting a Null Hypothesis: Exploring the Parameters of Oligometastasis Treatment,” along with @CancerConnector, @MartinTomMD, and @mike__kattan.
A 🧵 thread 🧵: redjournal.org/article/S0360…
1/7
2
20
50
Kevin Stephans MD retweeted
27 Oct 2020
Sharing our preliminary results at #ASTRO20 from our pilot study using fluciclovine PET to distinguish tumor recurrence from radiation necrosis. It holds promise, but further studies are needed. @CleClinicMD @DrJohnSuh @ErinMurphyMD #CleClinicCancer
1
18
52
Kevin Stephans MD retweeted
28 Apr 2020
Welcome @GeneCollector to @ClevelandClinic!! We greatly look forward to your leadership as head of the Center for Immunotherapy and Precision Immuno-oncology and working closely with you in #radonc. @ASTRO_org @CCLRI #CleClinicCancer
28 Apr 2020
We are thrilled to officially welcome @GeneCollector to LRI and Cleveland Clinic! Dr. Chan will lead our new Center for Immunotherapy and Precision Immuno-Oncology. For more on him and the center: tinyurl.com/yb6myq7k
2
9
59
Kevin Stephans MD retweeted
17 Apr 2020
Congratulations to my daughter Elizabeth for being awarded the ASTRO Minority Summer Research Fellowship. Thank you to her mentors Chirag Shah and Rahul Tendulkar for helping to keep the radiation oncology legacy going.
3
12
85
14 Apr 2020
Agree w @n8pennell, not only MRI screening but PET staging of initial disease also results in earlier stage overall, & less brain mets. Encourage participation in Maverick PRT of \- PCI for LS-SCLC, run by @cgr0105.
14 Apr 2020
Interesting study questioning benefit of PCI even in limited SCLC in the MRI surveillance era #LCSM: Prophylactic Cranial Irradiation, Survival, and Risk of Brain Metastasis in Patients With Small Cell Lung Cancer ja.ma/3b9RVSG
2